Price Alert

CollPlant Biotechnologies... (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

2.50

-0.11 (-4.21%)

At close: Aug 15, 2025, 3:57 PM

2.56

2.40%

After-hours: Aug 15, 2025, 06:26 PM EDT

CollPlant Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.73M	11.91M	15.37M	18.92M	23.46M	26.91M	28.98M	22.28M	26.53M	29.65M	32.81M	36.29M	41.07M	13.15M	25.75M	17.48M	19.72M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30.15M	20.1M	30.07M	30.02M
Long-Term Investments	n/a	n/a	n/a	n/a	57K	57K	54K	237K	240K	188K	187K	189K	208K	213K	205K	178K	174K
Other Long-Term Assets	117K	118K	115K	113K	57K	57K	54K	237K	240K	188K	187K	189K	208K	213K	205K	178K	174K
Receivables	440K	583K	431K	250K	90K	n/a	4K	10.16M	323K	9K	9K	9K	n/a	270K	135K	277K	174K
Inventory	673K	440K	454K	439K	645K	714K	1.5M	1.55M	1.78M	1.43M	1.13M	1.36M	1.27M	1.08M	1.15M	940K	1.27M
Other Current Assets	245K	248K	241K	726K	518K	634K	719K	863K	430K	566K	512K	617K	276K	437K	756K	991K	279K
Total Current Assets	12.09M	13.18M	16.5M	20.34M	24.48M	28.02M	31.21M	34.86M	29.06M	31.66M	34.46M	38.27M	42.62M	45.09M	47.9M	49.77M	51.47M
Property-Plant & Equipment	4.88M	5.28M	5.68M	5.96M	5.58M	5.86M	6.09M	6.26M	6.22M	5.68M	5.67M	5.72M	5.66M	5.68M	5.33M	4.91M	4.85M
Goodwill & Intangibles	116K	131K	145K	159K	173K	188K	202K	216K	231K	245K	238K	235K	239K	243K	194K	164K	138K
Total Long-Term Assets	5.12M	5.53M	5.95M	6.23M	5.82M	6.1M	6.35M	6.71M	6.7M	6.11M	6.1M	6.14M	6.11M	6.14M	5.73M	5.25M	5.17M
Total Assets	17.21M	18.71M	22.44M	26.57M	30.29M	34.13M	37.56M	41.57M	35.76M	37.77M	40.56M	44.41M	48.72M	51.22M	53.63M	55.02M	56.63M
Account Payables	770K	870K	1.01M	1.14M	1.12M	980K	744K	763K	885K	1.13M	880K	760K	1M	1.03M	865K	698K	894K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	32K	n/a	n/a	164K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	93K	n/a	n/a	n/a
Total Current Liabilities	2.7M	2.97M	3.07M	3.24M	3.42M	3.25M	2.63M	2.78M	2.92M	3.1M	2.33M	2.36M	2.61M	3.01M	2.52M	2.93M	3.38M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.11M	2.27M	2.46M	2.6M	2.42M	2.54M	2.53M	2.75M	2.95M	2.38M	2.42M	2.55M	2.92M	3.09M	2.64M	2.65M	2.61M
Total Liabilities	4.81M	5.25M	5.52M	5.84M	5.85M	5.79M	5.16M	5.53M	5.87M	5.49M	4.75M	4.91M	5.53M	6.1M	5.15M	5.58M	5.99M
Total Debt	2.84M	3.08M	3.25M	3.38M	3.02M	3.16M	3.1M	3.35M	3.48M	2.91M	2.9M	3.02M	3.43M	3.61M	3.33M	3.3M	3.26M
Common Stock	4.98M	4.98M	4.98M	4.98M	4.98M	4.98M	4.98M	4.96M	4.96M	4.87M	4.83M	4.83M	4.83M	4.66M	4.65M	4.45M	4.29M
Retained Earnings	-114.8M	-113.35M	-109.47M	-105.15M	-100.94M	-96.74M	-92.05M	-87.67M	-93.44M	-89.72M	-85.32M	-80.94M	-76.66M	-72.8M	-69.03M	-65.95M	-62.91M
Comprehensive Income	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K	-969K
Shareholders Equity	12.4M	13.46M	16.92M	20.73M	24.45M	28.34M	32.4M	36.04M	29.89M	32.28M	35.81M	39.51M	43.2M	45.12M	48.48M	49.44M	50.65M
Total Investments	n/a	n/a	n/a	113K	57K	57K	54K	237K	240K	188K	187K	189K	208K	30.15M	20.1M	30.07M	30.02M